These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 7420023)

  • 1. Central pyrogenic activity of muramyl dipeptide.
    Riveau G; Masek K; Parant M; Chedid L
    J Exp Med; 1980 Oct; 152(4):869-77. PubMed ID: 7420023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of endogenous pyrogen-induced fever by a muramyl dipeptide derivative.
    Parant M; Riveau G; Parant F; Chedid L
    Am J Physiol; 1984 Sep; 247(3 Pt 1):C169-74. PubMed ID: 6476105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of indomethacin on various immunopharmacological effects of muramyl dipeptide (MDP).
    Parant M; Riveau G; Chedid L
    Agents Actions Suppl; 1980; 7():33-40. PubMed ID: 6941684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in rabbit febrile responses to muramyl dipeptide (MDP) after coupling to a synthetic carrier.
    Riveau G; Parant M; Chedid L
    J Leukoc Biol; 1984 Aug; 36(2):111-22. PubMed ID: 6589335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of indomethacin on increased resistance to bacterial infection and on febrile responses induced by muramyl dipeptide.
    Parant M; Riveau G; Parant F; Dinarello CA; Wolff SM; Chedid L
    J Infect Dis; 1980 Nov; 142(5):708-15. PubMed ID: 7462686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of lymphocyte activating factor in the absence of endogenous pyrogen by rabbit or human leukocytes stimulated by a muramyl dipeptide derivative.
    Damais C; Riveau G; Parant M; Gerota J; Chedid L
    Int J Immunopharmacol; 1982; 4(5):451-62. PubMed ID: 6982246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pyrogenicity of the synthetic adjuvant muramyl dipeptide and two structural analogues.
    Dinarello CA; Elin RJ; Chedid L; Wolff SM
    J Infect Dis; 1978 Dec; 138(6):760-7. PubMed ID: 368262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissociation between muramyl dipeptide-induced fever and changes in plasma metal levels.
    Riveau G; Parant M; Damais C; Parant F; Chedid L
    Am J Physiol; 1986 Apr; 250(4 Pt 1):C572-7. PubMed ID: 3963170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muramyl dipeptide-induced sleep and fever: effects of ambient temperature and time of injections.
    Shoham S; Krueger JM
    Am J Physiol; 1988 Jul; 255(1 Pt 2):R157-65. PubMed ID: 3394839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decrease in pyrogenicity of muramyl dipeptide after coupling with luteinizing hormone-releasing hormone.
    Riveau G; Hosmalin A; Carelli C; Lefrancier P; Chedid L
    J Leukoc Biol; 1988 Nov; 44(5):448-54. PubMed ID: 3053952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of muramyl dipeptide on sleep, body temperature and plasma copper after intracerebral ventricular administration.
    Shoham S; Ahokas RA; Blatteis CM; Krueger JM
    Brain Res; 1987 Sep; 419(1-2):223-8. PubMed ID: 3676727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Course of fever response to repeated administration of sublethal doses of lipopolysaccharides, polyinosinic:polycytidylic acid and muramyl dipeptide to rabbits.
    Soszynski D; Kozak W; Szewczenko M
    Experientia; 1991 Jan; 47(1):43-7. PubMed ID: 1999244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-1-induced sleep and febrile responses differentially altered by a muramyl dipeptide derivative.
    Cady AB; Riveau G; Chedid L; Dinarello CA; Johannsen L; Krueger JM
    Int J Immunopharmacol; 1989; 11(8):887-93. PubMed ID: 2613394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of binding of MDP, a synthetic immunoadjuvant, to anti-peptidoglycan antibodies.
    Audibert F; Heymer B; Gros C; Schleifer KH; Seidl PH; Chedid L
    J Immunol; 1978 Oct; 121(4):1219-22. PubMed ID: 701793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the hepatic function in the development of the pyrogenic tolerance to muramyl dipeptide.
    Ferreira ME; Coelho MM; Pelá IR
    Am J Physiol Regul Integr Comp Physiol; 2001 Jul; 281(1):R162-9. PubMed ID: 11404290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunostimulant activities of a lipophilic muramyl dipeptide derivative and of desmuramyl peptidolipid analogs.
    Parant MA; Audibert FM; Chedid LA; Level MR; Lefrancier PL; Choay JP; Lederer E
    Infect Immun; 1980 Mar; 27(3):826-31. PubMed ID: 7380554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-acetyl muramyl dipeptide stimulation of bone resorption in tissue culture.
    Dewhirst FE
    Infect Immun; 1982 Jan; 35(1):133-7. PubMed ID: 7054120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereo-isomer specific induction of renal cell apoptosis by synthetic muramyl dipeptide (N-acetylmuramyl-L-alanyl-D-isoglutamine).
    Langford MP; Chen D; Welbourne TC; Redens TB; Ganley JP
    Mol Cell Biochem; 2002 Jul; 236(1-2):63-73. PubMed ID: 12190122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muramyl peptides as possible endogenous immunopharmacological mediators.
    Chedid L
    Microbiol Immunol; 1983; 27(9):723-32. PubMed ID: 6358804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muramyl dipeptide does not induce slow-wave sleep or fever in rats.
    Fornal C; Markus R; Radulovacki M
    Peptides; 1984; 5(1):91-5. PubMed ID: 6709515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.